Related Articles
Prognosis of patients with primary epithelial ovarian carcinoma who were not successfully cytoreduced
Nedaplatin and irinotecan combination therapy is equally effective and less toxic than cisplatin and irinotecan for patients with primary clear cell adenocarcinoma of the ovary and recurrent ovarian carcinoma
Adjuvant chemotherapy with irinotecan hydrochloride and cisplatin for clear cell carcinoma of the ovary
Activity of cytotoxic agents against clear cell carcinoma of the ovary which is intrinsically platinum-refractory
Long-term survival of patients with advanced colorectal cancer may not be due to the response to chemotherapy